IFP Advisors’s Zymeworks ZYME Stock Holding History

IFP Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.51K	Hold	96	–	–	﹤0.01%	4132
2026 Q1	$2.4K	Hold	96	–	–	﹤0.01%	3894
2025 Q4	$2.53K	Hold	96	–	–	﹤0.01%	3744
2025 Q3	$1.64K	Hold	96	–	–	﹤0.01%	3774
2025 Q2	$1.21K	Buy	+96	New	+$1.14K	﹤0.01%	4150
2025 Q1	–	Hold	0	–	–	–	4032
2024 Q4	–	Hold	0	–	–	–	4213
2023 Q3	–	Sell	-300	Closed	-$2.59K	–	3577
2023 Q2	$2.59K	Hold	300	–	–	﹤0.01%	2790
2023 Q1	$1.47K	Sell	300 -300	-50%	-$2.62K	﹤0.01%	2987
2022 Q4	$8K	Buy	600 +300	+100%	+$2.11K	﹤0.01%	3562
2022 Q3	$7K	Hold	300	–	–	﹤0.01%	3891
2022 Q2	$7K	Hold	300	–	–	﹤0.01%	3638
2022 Q1	$7K	Hold	300	–	–	﹤0.01%	3637
2021 Q4	$5K	Hold	300	–	–	﹤0.01%	2522
2021 Q3	$9K	Buy	300 +225	+300%	+$7.48K	﹤0.01%	2340
2021 Q2	$3K	Hold	75	–	–	﹤0.01%	2675
2021 Q1	$2K	Buy	+75	New	+$3.05K	﹤0.01%	2729

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

IFP Advisors's ZYME Position: Q2 2026 in Review

IFP Advisors held its Zymeworks (ZYME) position steady in Q2 2026 at 96 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4132.

IFP Advisors first reported a position in ZYME in Q1 2021 and has held it in 15 quarters since. The position peaked at $9K in Q3 2021. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

IFP Advisors held 96 shares of Zymeworks worth $2.51K as of Q2 2026.
IFP Advisors left its Zymeworks share count unchanged in Q2 2026.
Zymeworks made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4132 holding.
IFP Advisors first reported a position in Zymeworks in Q1 2021 and has held it in 15 quarters since.
IFP Advisors's Zymeworks position peaked at $9K in Q3 2021.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.